-
Document de presse | 2005.04.18
Newborn susceptibility to infection now deciphered
A joint Institut Pasteur-Inserm team has deciphered key mechanisms in the development of newborn immune systems. This study has made it possible to understand why infants are susceptible to early infections that cause high mortality rates, particularly in developing countries. Understanding these mechanisms offers possibilities for new types of treatment and vaccines adapted to protect newborns...
-
Document de presse | 2004.09.29
Procter & Gamble And Institut Pasteur Announce A Joint Collaboration To Develop A New Therapeutic Approach For Asthma
Procter & Gamble Pharmaceuticals (P&GP), a subsidiary of The Procter & Gamble Co. (NYSE: PG), and Institut Pasteur today announced an agreement under which P&GP will develop and seek market authorization for drug candidate EFD, a new type of immuno-modulator for the treatment of asthma and other allergic disorders, stemming from a joint research collaboration between Institut...
-
Document de presse | 2004.09.08
Human Genome: A New Mutagenic Phenomenon Revealed
Researchers from the Institut Pasteur associated with the CNRS have recently demonstrated the importance of the insertion of small sequences of mitochondrial DNA in the human genome (Public Library of Sciences, 7 September 2004). These insertions are potentially mutagenic and may be connected with serious pathologies. This research could enable the development of new diagnostic tools for cancer...
-
Article | 2017.03.16
Why support us?
The Institut Pasteur a non-profit foundation with recognized charitable status, is authorized to raise funds for its missions in the fields of research, public health and education. Your donations are directly given to the teams responsible for those missions – there's no intermediary.
-
Article | 2017.03.21
Apprenticeship tax
Giving your apprenticeship tax to the Institut Pasteur's Education Center means supporting advanced training for young scientists that will enable the medical discoveries of the future.
-
Article | 2017.03.27
Join Pasteurdon!
A national media eventEvery October, the Institut Pasteur organizes a fundraising weekend known as Pasteurdon to raise funds and awareness about its research among the general public.A number of companies are involved in this major fundraising event, alongside several television channels, 14 national radio stations, presenters and journalists, and a loyal patron: Alexandra Lamy.See the Pasteudon...
-
News | 2020.06.04
Study reveals conditions for the onset of severe forms of COVID-19
Using state-of-the-art sequencing and bioinformatics techniques, scientists from the Institut Pasteur, working with fellow scientists from Israel and China, determined that patients with severe forms of COVID-19 presented an abnormal, ineffective lymphocyte response and a massive infiltration of inflammatory cells in the lungs.Patients with COVID-19 (see the COVID-19 fact sheet)present a...
-
Article | 2020.07.27
Our mission
Our missionThe Institut Pasteur Technology Transfer and Industrial Partnership Department has generated close to 700 million euros in revenue over the last 15 years.The aim is to boost an open approach to future industry partners, from startups to major groups, to adapt more efficiently to the current and future requirements of society.The Technology Transfer and Industrial Partnership Department...
-
Document de presse | 2020.12.17
ComCor study on places of infection with SARS-CoV-2: where are French people catching the virus?
The Institut Pasteur, in partnership with the French National Health Insurance Fund (CNAM), Santé publique France and the Ipsos Social Research Institute, recently presented the results of the ComCor epidemiological study on circumstances and places of infection with the SARS-CoV-2 virus. The aim of the study was to identify the socio-demographic factors, places visited and behaviors associated...
-
Document de presse | 2021.03.09
ComCor: Study examining the sociodemographic, behavioral and practical factors associated with SARS-CoV-2 infection
The ComCor study is conducted by the Institut Pasteur in partnership with the French National Health Insurance Fund (CNAM), Ipsos and Santé publique France.Intermediate analysis, on March 1, 2021The ComCor study, which currently covers the period from October 1, 2020 to January 31, 2021, includes 77,208 participants with acute SARS-CoV-2 infection, excluding healthcare workers (8.2% of those...